Related Experiment Video
Updated: Sep 26, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
[Clinical evaluation on the duration of hospitalization for patients with pulmonary tuberculosis]
Tetsuro Inoue1, Eisaku Tanaka, Kazukiyo Oida
1Department of Respiratory Medicine, Tenri Hospital, 200 Mishimacho, Tenri-shi, Nara 632-8552, Japan. tetsuinoue@nyc.odn.ne.jp
Abstract:
In 1996, six-month short course regimen containing PZA was adopted as the standard method of chemotherapy for tuberculosis. According we reevaluated discharge criteria for patients with pulmonary tuberculosis and tried to shorten the duration of hospitalization. We investigated retrospectively the duration of hospitalization for patients with pulmonary tuberculosis who were admitted to the Tenri Hospital. PZA was used for 23.3% of patients who were admitted during 1992 to 1996 (group A, N = 200), and 80.1% of patients who were admitted during 1996 to 2000 (group B, N = 234). The time needed to bacterial negative conversion was significantly shortened from 2.5 months in group A to 1.8 months in group B. The mean duration of hospitalization for patients with pulmonary tuberculosis was significantly shortened from 133.8 days in group A to 63.7 days in group B. Moreover, the mean duration of hospitalization for patients with smear positive pulmonary tuberculosis was significantly shortened from 147.5 days in group A to 73.0 days in group B. There was no significant difference between group A and group B as to the rate of adverse reactions, discontinuation of drug taking and recurrence of the disease. We concluded that the duration of hospitalization for patients with pulmonary tuberculosis could be shortened by applying PZA in the initial phase of tuberculosis chemotherapy.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: